IMCD acquires Chinese food ingredient distributor Daoqin

IMCD, a leading global manufacturer/distributor of specialty chemicals and ingredients, announced that it has signed an agreement to acquire China Daoqin Biotech (Shanghai) Co., Ltd., a distributor of food and nutritional health ingredients, and its subsidiaries Longyu International Trading (Shanghai) Co., Ltd. and Longen Biotech (Guangzhou) Co., Ltd.

Founded in 2011, Daoqin specializes in the distribution of functional nutrition, health foods and food ingredients, providing innovative solutions to customers in the food, personal care and pharmaceutical industries through its professional technical team and laboratories. Headquartered in Shanghai, China, Daoqin has more than 20 employees and revenues of approximately RMB 122 million in 2023.

Nicky Huang, Managing Director of IMCD China, said: "The acquisition of Daoqin marks another step in our deepening layout in the food and nutrition market and broadens the scope of our life science business portfolio. With the acquisition of Daoqin, we are very pleased to welcome a very dedicated and talented team, and we will leverage complementary product portfolios and technical expertise to enhance capabilities and products in the local market."

Jack Ning, General Manager of Daoqin, said: "The Daoqin team is excited to join IMCD and believes that there are strong synergies between our businesses and capabilities. By leveraging IMCD's excellent global network and resources, we look forward to bringing greater innovation and value to customers in the Chinese life science market."

The completion of the transaction is subject to customary closing conditions and is expected to be completed in the second quarter of 2025.